Researchers have long been aware of the increased risk of breast cancer in diabetic women. A 2012 study, for instance, identified a rise of about 20% in breast cancer among diabetic women. However, a recent study has suggested that the long-term use of aspirin in low doses could significantly help reduce this risk. This research was carried out by a team of researchers from Taiwan, including Dr. Yi-Sun Yang from the Chung Shan Medical University, Taichung and was recently published in the Journal of Women’s Health.
Risk of Breast Cancer Reduced by Over 45 Percent
The research team retrieved data from Taiwan’s National Insurance Research Database and identified 148,739 diabetic women. Follow-ups of over 14 years allowed the team to gain a detailed assessment of breast cancer incidence among the women who took a daily low-dose of aspirin, which is about 76 to 165 milligrams every day.
When compared with women who did not take aspirin on a daily basis, the women who did take a daily course of the medicine were found to have an 18 percent lower likelihood of having breast cancer over 14 years. Moreover, the risk was found to be further reduced to 47 percent in women who took a high dose of the medicine, medically defined as at least 88,900 mg over the 14 years of follow up.
Findings Remain after Accounting for Several Confounding Factors too
Although further studies are required to confirm the link between the daily dose of aspirin and the reduced risk of breast cancer in diabetic women, the study shows immense promise in finding the link between diabetes and cancer. Moreover, it was also concluded in the study that the reduced risk of breast cancer on a daily dose of aspirin was also found to be equally promising after considering a number of confounding factors such as the presence of other illnesses and age of the participants.